Susquehanna International Group, LLP Mannkind Corp Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Mannkind Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 779,838 shares of MNKD stock, worth $5.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

779,838

Previous 1,911,322 59.2%

Holding current value

$5.32 Million

Previous $9.98 Million 50.92%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.01 - $6.7 $5.67 Million - $7.58 Million	-1,131,484 Reduced 59.2%	779,838 $4.9 Million
Q2 2024 Aug 15, 2024	BUY	$4.05 - $5.43 $6.08 Million - $8.15 Million	1,501,257 Added 366.1%	1,911,322 $9.98 Million
Q1 2024 May 07, 2024	SELL	$3.25 - $5.27 $779,824 - $1.26 Million	-239,946 Reduced 36.91%	410,065 $1.86 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $613,811 - $788,399	183,776 Added 39.42%	650,011 $2.37 Million
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.45 $349,076 - $486,565	-89,278 Reduced 16.07%	466,235 $1.93 Million
Q2 2023 Aug 11, 2023	SELL	$3.72 - $4.79 $1.16 Million - $1.49 Million	-311,298 Reduced 35.91%	555,513 $2.26 Million
Q1 2023 May 16, 2023	SELL	$3.95 - $5.63 $216,586 - $308,704	-54,832 Reduced 5.95%	866,811 $3.55 Million
Q4 2022 Feb 14, 2023	SELL	$3.02 - $5.37 $1.59 Million - $2.82 Million	-525,968 Reduced 36.33%	921,643 $4.86 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $2.12 Million - $3.09 Million	709,982 Added 96.25%	1,447,611 $4.47 Million
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $786,846 - $1.41 Million	-294,699 Reduced 28.55%	737,629 $2.81 Million
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $99,161 - $168,423	-37,848 Reduced 3.54%	1,032,328 $3.8 Million
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $433,669 - $575,014	-107,079 Reduced 9.1%	1,070,176 $4.68 Million
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $1.24 Million - $1.75 Million	318,783 Added 37.13%	1,177,255 $5.12 Million
Q2 2021 Aug 11, 2021	BUY	$3.61 - $5.45 $268,435 - $405,256	74,359 Added 9.48%	858,472 $4.68 Million
Q1 2021 May 17, 2021	SELL	$3.14 - $6.14 $1.45 Million - $2.84 Million	-462,140 Reduced 37.08%	784,113 $3.07 Million
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $721,128 - $1.63 Million	402,865 Added 47.77%	1,246,253 $3.9 Million
Q3 2020 Nov 16, 2020	SELL	$1.56 - $2.08 $610,237 - $813,650	-391,178 Reduced 31.69%	843,388 $1.59 Million
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $333,636 - $784,399	354,932 Added 40.35%	1,234,566 $2.16 Million
Q1 2020 May 15, 2020	BUY	$0.84 - $1.76 $275,891 - $578,057	328,442 Added 59.59%	879,634 $906,000
Q4 2019 Feb 14, 2020	SELL	$1.14 - $1.49 $141,215 - $184,570	-123,873 Reduced 18.35%	551,192 $711,000
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $361,548 - $500,605	347,643 Added 106.18%	675,065 $844,000
Q2 2019 Aug 16, 2019	BUY	$1.09 - $1.88 $9,270 - $15,989	8,505 Added 2.67%	327,422 $377,000
Q2 2019 Aug 14, 2019	BUY	$1.09 - $1.88 $253,882 - $437,889	232,920 Added 270.85%	318,917 $367,000
Q1 2019 May 15, 2019	SELL	$1.14 - $2.25 $144,953 - $286,092	-127,152 Reduced 59.65%	85,997 $169,000
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $29,953 - $60,200	-29,366 Reduced 12.11%	213,149 $226,000
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $147,086 - $318,929	-145,630 Reduced 37.52%	242,515 $444,000
Q2 2018 Aug 14, 2018	SELL	$1.59 - $2.38 $631,823 - $945,747	-397,373 Reduced 50.59%	388,145 $737,000
Q1 2018 May 15, 2018	SELL	$2.28 - $3.8 $2.75 Million - $4.59 Million	-1,207,132 Reduced 60.58%	785,518 $1.79 Million
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $3.28 Million - $9.66 Million	1,439,780 Added 260.42%	1,992,650 $4.62 Million
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $635,800 - $1.27 Million	552,870	552,870 $1.2 Million

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.76B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Mannkind Corp Transaction History